Publikationen von E. Friedlaender

Nagy, P.; Friedlaender, E.; Tanner, M.; Kapanen, A. I.; Carraway, K. L.; Isola, J.; Jovin, T. M.: Decreased accessibility and lack of activation of erbB2 in JIMT-1, a Herceptin-resistant, MUC-4-expressing breast cancer cell line. Cancer Research 65 (2), S. 473 - 482 (2005)

Friedlaender, E.; Nagy, P.; Arndt-Jovin, D. J.; Jovin, T. M.; Szoelloesi, J.; Vereb, G.: Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy. Cytometry 67, DOI: 10.1002/cyto.a.20173, S. 161 - 171 (2005)

Friedlaender, E.; Lidke, D. S.; Arndt-Jovin, D. J.; Jovin, T. M.; Szoelloesi, J.; Vereb, G.: Cell stimulation using Herceptin (R)-covered magnetic beads. Cytometry Part A 59A (1), S. 76 - 76 (2004)